LifeTech ScientificLFTSF 96 Pretax Margin % is 16.11% as of Dec. 2025, which is 50% below its 10-year median of 32.24. GuruFocus rates LFTSF with a GF Score™ of 96/100 and a GF Value™ of $0.36. The stock has 4 warning signs investors should review. Among 817 Medical Devices & Instruments companies, LifeTech Scientific ranks better than 76.99% on this metric.
The historical rank and industry rank for LifeTech Scientific's Pretax Margin % or its related term are showing as below:
LFTSF'
s Pretax Margin % Range Over the Past 10 Years
Min: 13.86 Med: 32.24 Max: 52.98
Current: 13.99
LFTSF's Pretax Margin % is ranked better than 76.99% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.4
vs LFTSF: 13.99
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
LifeTech Scientific Pretax Margin % Related Terms
LifeTech Scientific Pretax Margin % Historical Data
* Premium members only.
The historical data trend for LifeTech Scientific's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LFTSF vs ABT, SYK, MDT: Pretax Margin % Comparison
For the Medical Devices subindustry, LifeTech Scientific's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LifeTech Scientific Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, LifeTech Scientific's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where LifeTech Scientific's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LifeTech Scientific (LFTSF) has a Pretax Margin % of 16.11% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on LifeTech Scientific and its competitors. This is 50% below median its historical median of 32.24. Over the past decade, LifeTech Scientific's Pretax Margin % has ranged from 13.86 to 52.98. According to the industry distribution chart, LifeTech Scientific ranks #188 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 23%.
Is LifeTech Scientific's Pretax Margin % too high?
LifeTech Scientific's current Pretax Margin % of 16.11% is 50% below median its 10-year median of 32.24. Over the past 10 years, this metric has ranged from a low of 13.86 to a high of 52.98. The Medical Devices & Instruments industry median Pretax Margin % is 2.40. LifeTech Scientific's value of 16.11% is 571.3% above this industry median. Based on the distribution chart, LifeTech Scientific ranks #188 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, LifeTech Scientific has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does LifeTech Scientific's Pretax Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, LifeTech Scientific ranks #188 out of 817 companies for Pretax Margin %. This places LifeTech Scientific in the top 23% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 2.40. LifeTech Scientific's value of 16.11% is 571.3% above this benchmark. Historically, LifeTech Scientific's own Pretax Margin % has ranged from 13.86 to 52.98 over the past decade. While the company's 10-year median is 32.24 vs. the industry median of 2.40, LifeTech Scientific has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.40, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LifeTech Scientific's current Pretax Margin % of 16.11% is 571.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on LifeTech Scientific and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LifeTech Scientific's current Pretax Margin % is 16.11%, which is 50% below median its own 10-year median of 32.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeTech Scientific stock overvalued right now?
LifeTech Scientific (LFTSF) has a current Pretax Margin % of 16.11%. The stock's GF Value™ is $0.36, compared to a current price of $0.23 — trading 35.1% below its estimated fair value. The current Pretax Margin % is 16.11%, which is 50% below median its 10-year median of 32.24 and 571.3% above the Medical Devices & Instruments industry median of 2.40. LifeTech Scientific's overall GF Score™ is 96/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For LifeTech Scientific (LFTSF), the current Pretax Margin % is 16.11% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LifeTech Scientific (LFTSF) Overvalued in 2026?
Based on GuruFocus' analysis, LifeTech Scientific stock appears to be undervalued.
The current stock price of $0.23 is trading 35.1% below its estimated GF Value™ of $0.36.
Key valuation signals for LFTSF:
Pretax Margin %: 16.11% (50% below median its 10-year median of 32.24)
GF Value™: $0.36 vs. price of $0.23 (35.1% below fair value)
Industry Position: 571.3% above the Medical Devices & Instruments median (#188 of 817)
No single metric tells the full story. See the LFTSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LifeTech Scientific Corp develops and manufactures also responsible for marketing of minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The firm operates in three areas: the Structural heart diseases business, the Peripheral vascular diseases business, and the Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral Vascular Diseases business segment. Geographically, it derives a majority of its revenue from Mainland China, and it also has its presence in Europe, Asia, excluding mainland China and India, India, South America, Africa, and Others.
96GF Score
Get the complete analysis for LFTSF
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LFTSF has been successfully added to your 
